Obstetrician-gynecologists' practice patterns related to opioid use during pregnancy and postpartum-United States, 2017.

Autor: Ko JY; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS-S107-2, Atlanta, GA, 30341, USA. JeanKo@cdc.gov.; United States Public Health Service, Commissioned Corps, Rockville, Maryland, USA. JeanKo@cdc.gov., Tong VT; Division of Congenital and Developmental Disorders, National Center for Birth Defects and Developmental Disorders, Centers for Disease Control and Prevention, 4770 Buford Hwy, Atlanta, GA, 30341, USA., Haight SC; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy, MS-S107-2, Atlanta, GA, 30341, USA., Terplan M; Friends Research Institute, 1040 Park Ave Suite 103, Baltimore, MD, 21201, USA., Snead C; Research Department, American College of Obstetricians and Gynecologists (ACOG), 409 12th Street SW, Washington, DC, 20024, USA., Schulkin J; Department of Obstetrics and Gynecology, University of Washington School of Medicine, Box 356460, Seattle, WA, 98195, USA.
Jazyk: angličtina
Zdroj: Journal of perinatology : official journal of the California Perinatal Association [J Perinatol] 2020 Mar; Vol. 40 (3), pp. 412-421. Date of Electronic Publication: 2019 Oct 15.
DOI: 10.1038/s41372-019-0535-2
Abstrakt: Objective: To describe obstetrician-gynecologists' practices and attitudes related to opioid use among pregnant and postpartum women.
Study Design: A 2017 cross-sectional survey assessed U.S. obstetrician-gynecologists' (N = 462; response rate = 34%) practices (management) and attitudes (knowledge, preparedness, confidence, barriers, and resources needed) related to opioid use among pregnant and postpartum women. Modified Poisson regression determined adjusted prevalence ratios (aPR) for advising medication-assisted therapy (MAT) for pregnant women with opioid use disorder (OUD) by knowledge, confidence, and preparedness.
Results: Of respondents, 33% always or usually advised MAT to pregnant women with OUD. Confidence in treating pregnant women who use opioids (aPR: 1.3, 95% CI: 1.0-1.8) and knowledge that substance use services were covered under the Affordable Care Act (aPR: 1.4, 95% CI: 1.1-1.8) were associated with advising MAT.
Conclusion: Evidence suggests that efforts are needed to enhance physician confidence to manage pregnant and postpartum patients who use opioids, which may increase optimal care of this patient population.
Databáze: MEDLINE
Externí odkaz: